These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9761370)

  • 1. Donor-specific stimulation of peripheral blood mononuclear cells from recipients of orthotopic liver transplants is associated, in the absence of rejection, with type-2 cytokine production.
    Chung SW; Yoshida EM; Cattral MS; Hu Y; Gorczynski RM
    Immunol Lett; 1998 Sep; 63(2):91-6. PubMed ID: 9761370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of immunologic status of liver transplant recipients by peripheral blood mononuclear cells in response to stimulation by donor alloantigen.
    Chen Y; McKenna GJ; Yoshida EM; Buczkowski AK; Scudamore CH; Erb SR; Steinbrecher UP; Chung SW
    Ann Surg; 1999 Aug; 230(2):242-50. PubMed ID: 10450739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver nonparenchymal cells involved in hyporesponsiveness induced by portal vein injection of alloantigen.
    Chen Y; McKenna GJ; Ong C; Mui AL; Chung SW
    Immunol Lett; 2002 Apr; 81(1):1-11. PubMed ID: 11841840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time polymerase chain reaction analysis reveals an evolution of cytokine mRNA production in allograft acceptor mice.
    Xia D; Sanders A; Shah M; Bickerstaff A; Orosz C
    Transplantation; 2001 Sep; 72(5):907-14. PubMed ID: 11571458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linked unresponsiveness: early cytokine gene expression profiles in cardiac allografts following pretreatment of recipients with bone marrow cells expressing donor MHC alloantigen.
    Spriewald BM; Billing JS; Ensminger SM; Morris PJ; Wood KJ
    Cytokine; 2002 Jul; 19(1):6-13. PubMed ID: 12200107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance.
    Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
    J Immunol; 2001 May; 166(9):5619-28. PubMed ID: 11313402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine mRNA profiles in mouse orthotopic liver transplantation. Graft rejection is associated with augmented TH1 function.
    Thai NL; Fu F; Qian S; Sun H; Gao L; Wang SC; Demetris AJ; Woo J; Thomson AW; Duquesnoy RJ
    Transplantation; 1995 Jan; 59(2):274-81. PubMed ID: 7530874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor cell induced CD69 expression and intracellular IL-2 and IL-4 production by peripheral blood lymphocytes isolated from kidney transplant recipients.
    Paglieroni TG; Perez R; Katznelson S; Muto K; Chang T; Scott S; MacKenzie MR; Holland PV
    Hum Immunol; 1999 Jan; 60(1):41-56. PubMed ID: 9952026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin III inhibits lymphocyte proliferation, immunoglobulin production and mRNA expression of lymphocyte growth factors (IL-2, gamma-IFN and IL-4) in vitro.
    Zuo XJ; Nicolaidou E; Okada Y; Toyoda M; Jordan SC
    Transpl Immunol; 2001 Oct; 9(1):1-6. PubMed ID: 11680566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttransplant administration of donor leukocytes induces long-term acceptance of kidney or liver transplants by an activation-associated immune mechanism.
    Yan Y; Shastry S; Richards C; Wang C; Bowen DG; Sharland AF; Painter DM; McCaughan GW; Bishop GA
    J Immunol; 2001 Apr; 166(8):5258-64. PubMed ID: 11290811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominant expression of T helper 2 cytokines and altered expression of T helper 1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I major histocompatibility complex peptides.
    Shirwan H; Barwari L; Khan NS
    Transplantation; 1998 Dec; 66(12):1802-9. PubMed ID: 9884279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration.
    Plain KM; Boyd R; Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM
    Transplantation; 2007 Mar; 83(6):764-73. PubMed ID: 17414711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different patterns in donor-specific production of T-helper 1 and 2 cytokines by cells infiltrating the rejecting cardiac allograft.
    van Besouw NM; Daane CR; Vaessen LM; Balk AH; Claas FH; Zondervan PE; Jutte NH; Weimar W
    J Heart Lung Transplant; 1995; 14(5):816-23. PubMed ID: 8800715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rejection of spontaneously accepted rat liver allografts with recipientinterleukin-2 treatment or donor irradiation.
    Tu Y; Arima T; Flye MW
    Transplantation; 1997 Jan; 63(2):177-81. PubMed ID: 9020314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioredoxin priming prolongs lung allograft survival by promoting immune tolerance.
    Hu H; Zhu X; Joshi S; Lu L; Xia CQ; Patel JM
    PLoS One; 2015; 10(5):e0124705. PubMed ID: 25933390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy.
    Mottram PL; Han WR; Purcell LJ; McKenzie IF; Hancock WW
    Transplantation; 1995 Feb; 59(4):559-65. PubMed ID: 7878761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
    Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
    Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
    Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
    Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for persisting antigen, antigen presentation, and ICAM-1 in increased renal graft survival after oral or portal vein donor-specific immunization.
    Gorczynski RM; Chen Z; Zeng H; Fu XM
    Transplantation; 1998 Aug; 66(3):339-49. PubMed ID: 9721803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early immunological monitoring after pediatric liver transplantation: cytokine immune deviation and graft acceptance in 40 recipients.
    Gras J; Wieërs G; Vaerman JL; Truong DQ; Sokal E; Otte JB; Délépaut B; Cornet A; de Ville de Goyet J; Latinne D; Reding R
    Liver Transpl; 2007 Mar; 13(3):426-33. PubMed ID: 17318867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.